Advertisement
Screener

BULLFROG AI HOLDINGS, INC. (BFRG) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

2.8 / 5 stars · 68/120 Roast Me

BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 95.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2026-08-14

  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2026-03-31 was 95.00%, a 1.06% increase year-over-year.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2025-03-31 was 94.00%, a 3.30% increase year-over-year.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2024-03-31 was 91.00%, a 10.98% increase year-over-year.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2023-03-31 was 82.00%.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2025 was 94.00%, a 10.59% increase from fiscal 2024.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2024 was 85.00%, a 2.30% decline from fiscal 2023.
  • BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 87.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month
2026-06-3095.00%
10-Q · filed 2026-08-14
2026-03-3195.00%
10-Q · filed 2026-05-14
2025-12-3194.00%
10-K · filed 2026-03-19
2025-09-3094.00%
10-Q · filed 2025-11-14
2025-06-3094.00%
10-Q · filed 2026-08-14
2025-03-3194.00%
10-Q · filed 2026-05-14
2024-12-3185.00%
10-K · filed 2026-03-19
2024-09-3092.00%
10-Q · filed 2025-11-14
2024-06-3092.00%
10-Q · filed 2025-08-13
2024-03-3191.00%
10-Q · filed 2025-05-13
2023-12-3187.00%
10-K · filed 2025-03-14
2023-09-3087.00%
10-Q · filed 2024-11-08
2023-06-3087.00%
10-Q · filed 2024-08-07
2023-03-3182.00%
10-Q · filed 2024-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Tempest Therapeutics, Inc. (TPST)United States$0.013B